Raymond James & Associates Lantheus Holdings, Inc. Transaction History

Raymond James & Associates

  • $146 Billion
  • Q1 2024

A detailed history of Raymond James & Associates transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 18,050 shares of LNTH stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,050
Previous 13,920 29.67%
Holding current value
$1.42 Million
Previous $863,000 30.13%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
BUY
$51.07 - $68.26 $210,919 - $281,913
4,130 Added 29.67%
18,050 $1.12 Million
Q4 2023

Jan 16, 2024
SELL
$55.6 - $77.89 $910,394 - $1.28 Million
-16,374 Reduced 54.05%
13,920 $863,000
Q3 2023

Oct 24, 2023
SELL
$60.27 - $90.75 $36,162 - $54,450
-600 Reduced 1.94%
30,294 $2.1 Million
Q2 2023

Jul 25, 2023
BUY
$82.41 - $99.65 $813,304 - $983,445
9,869 Added 46.94%
30,894 $2.59 Million
Q1 2023

Apr 14, 2023
BUY
$47.76 - $82.86 $250,453 - $434,517
5,244 Added 33.23%
21,025 $1.74 Million
Q4 2022

Feb 08, 2023
SELL
$48.76 - $77.67 $591,702 - $942,525
-12,135 Reduced 43.47%
15,781 $804,000
Q3 2022

Oct 25, 2022
BUY
$61.42 - $86.29 $972,278 - $1.37 Million
15,830 Added 130.98%
27,916 $1.96 Million
Q2 2022

Aug 12, 2022
SELL
$55.54 - $72.65 $187,947 - $245,847
-3,384 Reduced 21.87%
12,086 $798,000
Q1 2022

May 11, 2022
BUY
$24.28 - $56.64 $375,611 - $876,220
15,470 New
15,470 $856,000
Q4 2020

Feb 12, 2021
SELL
$10.75 - $14.91 $120,701 - $167,409
-11,228 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$11.98 - $16.34 $8,613 - $11,748
719 Added 6.84%
11,228 $142,000
Q2 2020

Jul 28, 2020
BUY
$10.34 - $15.51 $108,663 - $162,994
10,509 New
10,509 $150,000
Q3 2019

Nov 07, 2019
SELL
$21.01 - $28.94 $237,770 - $327,513
-11,317 Closed
0 $0
Q2 2019

Aug 06, 2019
SELL
$23.33 - $28.3 $70,619 - $85,664
-3,027 Reduced 21.1%
11,317 $320,000
Q1 2019

May 06, 2019
BUY
$14.93 - $25.1 $9,958 - $16,741
667 Added 4.88%
14,344 $351,000
Q4 2018

Feb 11, 2019
SELL
$12.68 - $19.01 $14,303 - $21,443
-1,128 Reduced 7.62%
13,677 $214,000
Q3 2018

Nov 14, 2018
SELL
$13.1 - $16.35 $9,903 - $12,360
-756 Reduced 4.86%
14,805 $221,000
Q2 2018

Aug 14, 2018
BUY
$13.65 - $18.7 $64,441 - $88,282
4,721 Added 43.55%
15,561 $226,000
Q1 2018

May 14, 2018
BUY
$14.85 - $24.3 $160,974 - $263,412
10,840 New
10,840 $172,000

Others Institutions Holding LNTH

# of Institutions
443
Shares Held
65.1M
Call Options Held
1.47M
Put Options Held
771K
View Full List

About Lantheus Holdings, Inc.

LNTH Quotes by TradingView
  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.4B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email